From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
CAS Number
  • 2033-94-5 ☑Y
PubChem CID
  • 16252
  • 15421 ☒N
Chemical and physical data
Formula C11H12O2
Molar mass 176.212 g/mol
3D model (JSmol)
  • Interactive image
 ☒N☑Y (what is this?)   (verify)

Centalun was developed by Boehringer Ingelheim in 1962[1] and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor.[2] It was previously used for sedation in medical procedures such as surgery,[3] orthopedics[4] and gynecology,[5] although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse.


  1. ^ BE Patent 618130 'Procédé pour l'obtention d'alkinediols'
  2. ^ Janke, W.; Glathe, H. (1964). "Experimental Studies on the Psychic Effect of Sedatives Under Normal and Stress Conditions". Psychologische Forschung. 27: 377–402. PMID 14233519.
  3. ^ Monecke, K. (1964). "Pre- and Postoperative Use of Centalun in Surgery". Deutsches medizinisches Journal. 15: 470–471. PMID 14238754.
  4. ^ Bruckschen, E. (1964). "Sedative Therapy with Centalun in Orthopedics". Deutsches medizinisches Journal. 15: 493–494. PMID 14243120.
  5. ^ Gerlach, W.; Gerlach, E. (1964). "Experiences with Centalun in Obstetrical and Gynecological Patients". Medizinische Monatsschrift. 18: 131–133. PMID 14193290.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Centalun&oldid=846161547"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Centalun
This page is based on the copyrighted Wikipedia article "Centalun"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA